pharma · Progressive supranuclear palsy (PSP) · Amyotrophic Lateral Sclerosis
Dr. Ferrer BioPharma
Ferrer Internacional S.A.
Dr. Ferrer BioPharma patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Hallandale Beach, USA
- Founded
- 2020
- Employees
- 11
- Programs
- 2
- Drugs
- 2
- Patents
- 0
Dr. Ferrer BioPharma patents
0 pharmaceutical patents indexed for Dr. Ferrer BioPharma. 0 expire within 24 months.
Dr. Ferrer BioPharma has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does Dr. Ferrer BioPharma have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Dr. Ferrer BioPharma patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.